logo

Last Update

This profile was last updated on 10/25/2011 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Massimo Martelli?

Massimo F. Martelli

Full Professor and Head of the Umbria Region Bone Marrow Transplantation Program

University of Perugia

HQ Phone:  +39 075 5851

Email: e***@***.it

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of Perugia

Università degli Studi di Perugia P.zza Università, 1

Perugia, Umbria,06100

Italy

Web References(11 Total References)


Early Infusion of Donor T Regulatory Cells Prevents Graft-versus-Host Disease and Enhances Immune Recovery in High-Risk Blood Cancer Patients

cms.hematology.org [cached]

"Our aim was to determine if patient outcomes could be improved if Tregs were introduced early in the transplantation process," said senior study author Massimo F. Martelli, MD, Full Professor and Head of the Umbria Region Bone Marrow Transplantation Program at the University of Perugia.


www.hemonctoday.com

Researchers, including Massimo F. Martelli, MD, professor and head of hematology at the University of Perugia, Italy, hope that this new method will reduce infection-related mortality associated with high-dose stem cell transplants, and therefore, improve OS of these patients.
Martelli presented the data during a press conference at the 51st ASH Annual Meeting.


www.eurekalert.org

"This study demonstrates that T-regulatory cell-based therapy may be an innovative strategy to improve the outcome of patients who undergo bone marrow transplants," said Massimo F. Martelli, MD, Professor and Head of the Hematology and Clinical Immunology Section at the University of Perugia in Italy and senior author of this study.
"We hope that this new method will reduce infection-related mortality and thus improve overall survival." Dr. Martelli will present this study in the Plenary Scientific Session on Sunday, December 6, at 2:45 p.m. in Hall F.


Preliminary scientific program

www.european-americangeneticsmeetings.org [cached]

Massimo Martelli University of Perugia, Perugia, Italy


Nuova pagina 4

www.costb19.net [cached]

Head: Massimo F Martelli, tel: +390 75 5783219, fax: +390 75 5783691, e-mail: ematol@unipg.it


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory